Literature DB >> 17380741

Oncolytic herpes simplex virus mutants exhibit enhanced replication in glioma cells evading temozolomide chemotherapy through deoxyribonucleic acid repair.

Manish Aghi1, Samuel Rabkin, Robert L Martuza.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17380741

Source DB:  PubMed          Journal:  Clin Neurosurg        ISSN: 0069-4827


× No keyword cloud information.
  3 in total

1.  MGMT modulates glioblastoma angiogenesis and response to the tyrosine kinase inhibitor sunitinib.

Authors:  Manik Chahal; Yaoxian Xu; David Lesniak; Kathryn Graham; Konrad Famulski; James G Christensen; Manish Aghi; Amanda Jacques; David Murray; Siham Sabri; Bassam Abdulkarim
Journal:  Neuro Oncol       Date:  2010-02-23       Impact factor: 12.300

Review 2.  Oncolytic HSV-1 virotherapy: clinical experience and opportunities for progress.

Authors:  Balveen Kaur; E Antonio Chiocca; Timothy P Cripe
Journal:  Curr Pharm Biotechnol       Date:  2012-07       Impact factor: 2.837

Review 3.  Oncolytic virotherapy for urological cancers.

Authors:  Zahid Delwar; Kaixin Zhang; Paul S Rennie; William Jia
Journal:  Nat Rev Urol       Date:  2016-05-24       Impact factor: 14.432

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.